Vaccine countdown update: 17 Nov (2) - quality is worth the premium
Quality is worth paying a premium for and a company covered here has many of the attributes of an extremely good business. Others look more challenged, as you can discover here.
AdEPT: results underwhelm
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on AdEPT Technology
Chain gains | Another takeover | Big dividend
News covered here includes a promising update from a lowly valued engineering group, another equity raise…
As frustrating as ever
News from AIM covered here, include results from one of AIM’s more elderly companies and one…
More on Craneware
Outrageous remuneration | Fabulous results | Cracking bargain
News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…
Episode 32 of the Investor’s Champion Podcast
This episode of the Investor’s Champion Podcast includes a discussion of changes to the Income Boosters Portfolio…
More on dotDigital
Challenging outlooks | Reassuringly boring | Hidden value
News covered here includes our assessment of two small caps facing challenging markets. Elsewhere, a fast…
Stonking Small Cap reports cracking results
This brilliant little company has delivered consistent excellence over a number of years, yet it still has…
More on Eagle Eye Solutions
Flush with cash | Special dividends | Corporate undertakers
News covered here includes our assessment of updates and results from an eclectic mix of elderly…
Fast growers | Big dividends
We reflect here on announcements from very different companies. While one has the appeal of very strong growth,…
More on IDOX
Delightful reporting | AI attributes | Puzzling business
Our review here includes our thoughts on the latest update from a popular developer of video…
Animal spirits
We offer our usual forthright opinion on trading updates from two companies in the animal health…
More on Scapa Group
Scaparing!
This AIM struggler is getting acquired by a US listed company. While the acquisition price is…
Vaccine countdown update: 17 Nov (2) - quality is worth the premium
Quality is worth paying a premium for and a company covered here has many of the…
